COVID-19 prophylaxis: half-full or half-empty glass?

Blood. 2023 Jan 12;141(2):130-132. doi: 10.1182/blood.2022018858.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Neoplasms*
  • SARS-CoV-2

Substances

  • tixagevimab
  • cilgavimab